IL153687A0 - Composition and method for enhancing elasticity of tissue - Google Patents

Composition and method for enhancing elasticity of tissue

Info

Publication number
IL153687A0
IL153687A0 IL15368701A IL15368701A IL153687A0 IL 153687 A0 IL153687 A0 IL 153687A0 IL 15368701 A IL15368701 A IL 15368701A IL 15368701 A IL15368701 A IL 15368701A IL 153687 A0 IL153687 A0 IL 153687A0
Authority
IL
Israel
Prior art keywords
tissue
composition
enhancing elasticity
enhancing
elasticity
Prior art date
Application number
IL15368701A
Original Assignee
Connective Tissue Imagineering
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/584,001 external-priority patent/US6506731B1/en
Priority claimed from US09/580,893 external-priority patent/US6794362B1/en
Priority claimed from US09/580,110 external-priority patent/US6809075B1/en
Priority claimed from US09/580,156 external-priority patent/US6962904B1/en
Application filed by Connective Tissue Imagineering filed Critical Connective Tissue Imagineering
Publication of IL153687A0 publication Critical patent/IL153687A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15368701A 2000-05-30 2001-05-30 Composition and method for enhancing elasticity of tissue IL153687A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/584,001 US6506731B1 (en) 1998-03-13 2000-05-30 Elastin peptide analogs and methods of using same
US09/580,893 US6794362B1 (en) 2000-05-30 2000-05-30 Asparagine containing elastin peptide analogs
US09/580,110 US6809075B1 (en) 2000-05-30 2000-05-30 Elastin peptide analogs and uses of same incombination with skin enhancing agents
US09/580,156 US6962904B1 (en) 1998-03-13 2000-05-30 Elastin peptide analogs and uses thereof
PCT/US2001/017384 WO2001091700A2 (en) 2000-05-30 2001-05-30 Composition and method for enhancing elasticity of tissue

Publications (1)

Publication Number Publication Date
IL153687A0 true IL153687A0 (en) 2003-07-06

Family

ID=27504943

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15368701A IL153687A0 (en) 2000-05-30 2001-05-30 Composition and method for enhancing elasticity of tissue

Country Status (7)

Country Link
EP (1) EP1392346A4 (en)
AU (2) AU2001275018B2 (en)
CA (1) CA2415225A1 (en)
IL (1) IL153687A0 (en)
NO (1) NO20030454L (en)
NZ (1) NZ523403A (en)
WO (1) WO2001091700A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827170B1 (en) * 2001-07-13 2004-07-16 Soc Extraction Principes Actif USE OF PEPTIDES TO INCREASE CELL ADHESION
WO2003030860A1 (en) * 2001-10-05 2003-04-17 Procyte Corporation Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof
KR20050033510A (en) * 2001-10-05 2005-04-12 프로사이트 코포레이션 Methods for the treatment of hyperpigmentation of skin
US20040138103A1 (en) * 2002-11-07 2004-07-15 Procyte Corporation Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto
DE10260928A1 (en) * 2002-12-20 2004-07-08 Henkel Kgaa Method for the determination of markers of human facial skin
US6927205B2 (en) 2003-04-28 2005-08-09 Procyte Corporation Compositions and methods for treatment of psoriasis
FR2854897B1 (en) * 2003-05-12 2007-05-04 Sederma Sa COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS FOR REDUCING THE SIGNS OF SKIN AGING.
EP1765280A1 (en) * 2004-06-28 2007-03-28 Procyte Corporation Methods and compositions for preventing and treating hyperpigmentation of skin
CA2652388A1 (en) 2006-05-15 2007-11-22 Valio Ltd New use of therapeutically useful peptides
WO2008100789A2 (en) 2007-02-16 2008-08-21 Benaroya Research Institute At Virginia Mason Compositions and methods for altering elastogenesis
CN103458911B (en) 2011-02-11 2016-02-24 密歇根大学董事会 Peptide combinations and the method being used for the treatment of patient
MX2013010977A (en) 2011-03-31 2013-10-30 Procter & Gamble Systems, models and methods for identifying and evaluating skin-active agents effective for treating dandruff/seborrheic dermatitis.
JP2015527630A (en) 2012-06-06 2015-09-17 ザ プロクター アンド ギャンブルカンパニー Cosmetic identification system and method for hair / scalp care composition
FR3116273B1 (en) * 2020-11-17 2023-10-27 Sederma Sa Tetrapeptides, compositions comprising them and their cosmetic use
KR102484277B1 (en) * 2021-11-22 2023-01-04 대한켐텍 주식회사 Manufacturing Method Of Raw Material Composition For Improving Skin Beauty

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
DE19715103A1 (en) * 1997-04-11 1998-10-15 Targor Gmbh Metallocene amino acid and peptide complexes
WO1998047921A1 (en) * 1997-04-21 1998-10-29 Schering Corporation Mammalian cytokines; related reagents and methods
US6069129A (en) * 1998-03-13 2000-05-30 Mrs, Llc Elastin derived composition and method of using same
EP1054677B1 (en) * 1998-11-19 2008-10-22 Connective Tissue Imagineering LLC Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides
AU784203B2 (en) * 1999-10-29 2006-02-23 Glaxosmithkline Biologicals S.A. Neisserial antigenic peptides

Also Published As

Publication number Publication date
NZ523403A (en) 2005-04-29
WO2001091700A2 (en) 2001-12-06
EP1392346A4 (en) 2006-10-25
AU2001275018B2 (en) 2008-04-03
NO20030454D0 (en) 2003-01-29
NO20030454L (en) 2003-01-29
CA2415225A1 (en) 2001-12-06
EP1392346A2 (en) 2004-03-03
WO2001091700A8 (en) 2003-11-20
AU7501801A (en) 2001-12-11

Similar Documents

Publication Publication Date Title
AU8657601A (en) Composition and method for treatment of hypertriglyceridemia
AU2002230831A1 (en) Compositions of human proteins and method of use thereof
IL213845A0 (en) Method and composition for treatment of skeletal dysplasias
AU1166502A (en) Human ect2 and methods of use
EP1157707B8 (en) Method and composition for deforming soft tissues
GB0014969D0 (en) Novel method of treatment
EP1438062A4 (en) Methods and compositions for treating dermal lesions
GB0110288D0 (en) Composition and treatment method
AU6832101A (en) Composition and method
AU4163402A (en) Composition and method
AU7501801A (en) Composition and method for enhancing elasticity of tissue
HK1047879A1 (en) Improved prosthesis and method therefor
AU7311501A (en) Cosmetic composition and method
HU0104832D0 (en) Cosmetic composition and method
AU2001234831A1 (en) Magnetoliposome composition for targeted treatment of biological tissue and associated methods
AU2003282593A8 (en) Polyphenolamine composition and method of use
EP1263935A4 (en) Scytonemin and methods of using thereof
GB2399500B (en) Composition and method for treatment of wounds
GB0008921D0 (en) Method of treatment
IL151403A0 (en) Compositions and methods for treatment of epilepsy
GB0105472D0 (en) Smoke composition and method of use thereof
AU2001253469A1 (en) Compositions and methods for stabilizing modified tissue
EP1272512A4 (en) Immunokine composition and method
EP1303281A4 (en) Methods of treatment
GB0016437D0 (en) Method of and composition for tattooing